This is a protocol preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Method Article
Birgit Obermeier
Institute of Clinical Neuroimmunology, Ludwig-Maximilians University, D-81377 Munich, Germany
Corresponding Author
License:
This work is licensed under a CC BY 4.0 License. Read Full License
We describe a protocol for the direct molecular characterization of expanded antibody species detectable in minute amounts in human cerebrospinal fluid or other body fluids and tissues against a huge background of irrelevant antibodies. Antibodies are purified by affinity chromatography and applied to high resolution 2-dimensional PAGE under non-reducing conditions. Individual heterodimers consisting of heavy and light chains are isolated and analyzed by mass spectrometry. Since this rarely yields full sequence coverage, we reveal the complete sequences by alignment of the peptides to the immunoglobulin transcriptome of the same patient. Recombinant antibodies may then be produced and used for antigen searches or other experiments. We have analyzed antigens of oligoclonal band antibodies from the cerebrospinal fluid of patients with neurological inflammatory diseases, but the technology, which takes about two weeks, may be applied to many disease-relevant (auto)antibodies in human infectious and autoimmune diseases, as well as to B-cell malignancies.
Keywords
Oligoclonal band antibodies, B cells, Immunoglobulin, Proteomics, Transcriptomics, neurological inflammatory diseases
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
The authors declare that they have no competing financial interests. Birgit Obermeier is now an employee at Biogen, but was affiliated with the Ludwig-Maximilians University at the time the study was performed, i.e. Biogen was not a sponsor of this study.
This is a list of supplementary files associated with this preprint. Click to download.
- supplement0.pdf
Table 1 Overview on the properties of the different approaches to generate Ig transcriptome databases
Loading...
Version History
CURRENT STATUS: Posted
Version 1
Posted 20 Oct, 2017
No community comments so far
Metrics
Comments: 0
HTML Views: ...
Associated Publications
Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins
by Simone M. Brändle, Birgit Obermeier, Makbule Senel, +10
Proceedings Of The National Academy Of Sciences (06 September, 2017)
Method Article
Birgit Obermeier
Institute of Clinical Neuroimmunology, Ludwig-Maximilians University, D-81377 Munich, Germany
Corresponding Author
Version History
CURRENT STATUS: Posted
Version 1
Posted 20 Oct, 2017
No community comments so far
Metrics
Comments: 0
HTML Views: ...
License:
This work is licensed under a CC BY 4.0 License. Read Full License
We describe a protocol for the direct molecular characterization of expanded antibody species detectable in minute amounts in human cerebrospinal fluid or other body fluids and tissues against a huge background of irrelevant antibodies. Antibodies are purified by affinity chromatography and applied to high resolution 2-dimensional PAGE under non-reducing conditions. Individual heterodimers consisting of heavy and light chains are isolated and analyzed by mass spectrometry. Since this rarely yields full sequence coverage, we reveal the complete sequences by alignment of the peptides to the immunoglobulin transcriptome of the same patient. Recombinant antibodies may then be produced and used for antigen searches or other experiments. We have analyzed antigens of oligoclonal band antibodies from the cerebrospinal fluid of patients with neurological inflammatory diseases, but the technology, which takes about two weeks, may be applied to many disease-relevant (auto)antibodies in human infectious and autoimmune diseases, as well as to B-cell malignancies.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Loading...
Associated Publications
Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins
by Simone M. Brändle, Birgit Obermeier, Makbule Senel, +10
Proceedings Of The National Academy Of Sciences (06 September, 2017)